£134.29↓ 22%
Variants1
| Variant | Price | unit |
|---|---|---|
| 1 pen | £134.29 | £134.29/pen |
Shipping
Next day tracked 24 RM no sig£5.97RM Special Delivery (next day)£11.19
| Variant | Price | unit |
|---|---|---|
| 1 pen | £134.29 | £134.29/pen |
40mg pre mixed retatrutide weigh loss pens for sale... Weight-loss benefits Large, clinically meaningful weight reduction: Early-phase trials report higher average weight loss than dual GLP‑1/GIP agonists (e.g., tirzepatide), with many participants reaching 15–20%+ body weight loss over several months. Fast onset of effect: Weight loss often begins within the first few weeks and continues steadily with dose escalation. Strong appetite suppression: Reduced hunger, fewer cravings, and lower desire for high-calorie foods, leading to sustained calorie reduction. Fat loss with muscle preservation: When protein intake and resistance training are maintained, loss is predominantly fat, helping preserve lean mass. Health benefits Metabolic improvements: Lower fasting glucose and HbA1c, improved insulin sensitivity, and better post-meal glucose control. Cardiovascular risk factors: Reductions in blood pressure, triglycerides, and LDL cholesterol; improved overall lipid profile. Liver benefits: Decreased liver fat and improvements in markers associated with metabolic dysfunction–associated steatotic liver disease (MASLD). Inflammation: Lower systemic inflammation markers (e.g., CRP) in trial settings. Sleep apnea: Weight loss often reduces obstructive sleep apnea severity.
